Export

EN
FR
ATC codes: L01XA02
Indication
Other specified carcinomas of ovary ICD11 code: 2D23.0Y
INN
Carboplatin
Medicine type
Chemical agent
List type
Complementary
Formulations
Parenteral > General injections > IV: 50 mg per 5 mL ; 150 mg per 15 mL ; 450 mg per 45 mL ; 600 mg per 60 mL
EML status history
First added in 2009 (TRS 958)
Changed in 2015 (TRS 994)
Sex
Female
Age
Adolescents and adults
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Tags
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
In 2015, as part of the comprehensive review of cancer medicines undertaken by the Expert Committee, the listing for carboplatin on the EML for use in treatment protocols for epithelial ovarian cancer was specifically endorsed. The relevant extract from TRS994 regarding the Expert Committee's 2015 consideration of treatment protocols for epithelial ovarian cancer is attached.